["{\n\"step_by_step_thinking\": \"The patient presents with a 6-month history of abdominal bloating, upper abdominal discomfort, and constipation. The symptoms are more severe when she is preparing for examinations but improve after bowel movements. This suggests that the patient may be experiencing irritable bowel syndrome (IBS) or a functional gastrointestinal disorder. Given the patient's age, height, weight, and physical examination findings, there is no obvious underlying medical condition that would suggest pharmacotherapy with azathioprine, infliximab, or mesalamine.\n\nThe patient's symptoms are consistent with IBS-C (constipation-predominant irritable bowel syndrome), which often responds well to laxatives. Lubiprostone, a selective chloride channel activator, is approved by the FDA for the treatment of chronic constipation in adults and has been shown to be effective in reducing symptoms of IBS-C.\",\n\"answer_choice\": \"C\"\n}"]